
September 2014
References to Documentary Evidence in Lieu of Source Code Are Sufficient to Create Genuine Issue of Material Fact
No. 13-1212 (Fed. Cir. Aug. 1, 2014)
[Appealed from E.D. Va., Judge Brinkema]
Claims That Omit a Feature Described in the Specification Do Not Lack Written Description Support
[Appealed from D. Kan., Judge Murguia]
Hatch-Waxman Infringement Claims and FDA Citizen Petition May Violate Antitrust Laws
[Appealed from D.N.J., Judge Chesler]
Where Patentee Made Affirmative and Knowing Misrepresentations Regarding the Prior Art, Materiality Element of Inequitable-Conduct Analysis Was Met
[Appealed from S.D. Fla., Judge Middlebrooks]
Species Are Unpatentable When Prior Art Disclosures Describe the Genus Such That a Person of Ordinary Skill in the Art Would Be Able to Envision Every Member of the Class
[Appealed from S.D.N.Y., Judge Crotty]
District Court Did Not Err by Clarifying Claim Construction in Postverdict JMOL Opinion
[Appealed from N.D. Cal., Judge Chen]
| Abbreviations | |
| ALJ | Administrative Law Judge |
| ANDA | Abbreviated New Drug Application |
| APA | Administrative Procedures Act |
| APJ | Administrative Patent Judge |
| Board | Patent Trial and Appeal Board (formerly the Board of Patent Appeals and Interferences) |
| Commissioner | Commissioner of Patents and Trademarks |
| CIP | Continuation-in-Part |
| DJ | Declaratory Judgment |
| DOE | Doctrine of Equivalents |
| FDA | Food and Drug Administration |
| IDS | Information Disclosure Statement |
| ITC | International Trade Commission |
| JMOL | Judgment as a Matter of Law |
| MPEP | Manual of Patent Examining Procedure |
| NDA | New Drug Application |
| PCT | Patent Cooperation Treaty |
| PTO | United States Patent and Trademark Office |
| SJ | Summary Judgment |
| TTAB | Trademark Trial and Appeal Board |
